Limits on medicare's ability to control rising spending on cancer drugs Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Drug Costs
  • Medicare
  • Reimbursement Mechanisms

abstract

  • During the past decade, the price of cancer drugs and the spending for cancer treatments by Medicare have increased dramatically. The author outlines the usual tools Medicare uses to control its spending on drugs and discusses the policies that make cancer drugs a special case and prohibit the regulation of their prices and utilization Copyright © 2009 Massachusetts Medical Society.

publication date

  • February 5, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 19176475

Additional Document Info

start page

  • 626

end page

  • 33

volume

  • 360

number

  • 6